株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

CRRT (持続的腎代替療法) の世界市場:市場状況・市場機会・市場シェア・市場規模の分析・予測 (2016-2022年)

Global Continuous Renal Replacement Therapy (CRRT) Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022

発行 Occams Business Research & Consulting Pvt. Ltd. 商品コード 362381
出版日 ページ情報 英文 140 Pages
納期: お問合せ
価格
本日の銀行送金レート: 1USD=107.66円で換算しております。
Back to Top
CRRT (持続的腎代替療法) の世界市場:市場状況・市場機会・市場シェア・市場規模の分析・予測 (2016-2022年) Global Continuous Renal Replacement Therapy (CRRT) Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022
出版日: 2016年07月04日 ページ情報: 英文 140 Pages
概要

世界のCRRT (持続的腎代替療法) 市場は予測期間中、7.69%のCAGR (複合年間成長率) で推移し、2022年には12億9000万米ドルの規模に成長すると予測されています。

当レポートでは、世界のCRRT (持続的腎代替療法) の市場を調査し、市場およびCRRT療法の定義と概要、市場への影響因子および市場機会の分析、R&Dの動向、主な成長市場・新興動向の分析、治療法・製品区分・地域/主要国別の動向と市場規模の推移と予測、競合環境と市場シェア、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 市場概要

  • 市場の定義・範囲
  • 主要調査結果
  • パラメトリック分析
  • 市場分析
    • 新興国トップ3
    • 収益生成部門トップ3
    • 主な成長市場・新興動向
    • R&Dシナリオ
    • 価格分析
  • 競合環境
    • 市場シェア分析
    • 主要成功戦略
    • ケーススタディ
  • バリューチェーン分析
  • 主な購買基準
  • 戦略的提言
  • 戦略的総論

第3章 市場影響因子

  • 市場成長推進因子
  • 市場成長阻害因子
  • 市場課題
  • 市場機会

第4章 関連市場の分析

  • 親市場
  • 詳細区分別市場
  • 代替市場

第5章 市場分析:区分別

  • 世界市場の予測:治療法別
    • 持続緩徐式限外濾過 (SCUF:SLOW CONTINUOUS ULTRA FILTRATION)
    • 持続静脈静脈血液濾過 (CVVH:CONTINUOUS VENOVENOUS HEMOFILTRATION)
    • 持続静脈静脈血液透析 (CVVHD:CONTINUOUS VENOVENOUS HEMODIALYSIS)
    • 持続静脈静脈血液透析濾過 (CVVHDF:CONTINUOUS VENOVENOUS HEMODIAFILTRATION)
  • 世界市場の予測:製品別
    • CRRTシステム/マシン
    • 流体フィルター
    • 血液浄化装置
    • 血液ラインシステム
    • CRRTソリューション
    • CRRT濃縮物
    • 透析器
    • その他

第6章 競合環境

  • 市場シェア
  • 戦略

第7章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • フランス
    • ドイツ
    • スペイン
    • イタリア
    • その他
  • アジア太平洋
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • その他
  • その他の地域
    • ラテンアメリカ
    • 中東・北アフリカ
    • アフリカ

第8章 企業プロファイル

  • BAXTER INTERNATIONAL
  • GAMBRO BAXTER
  • B. BRAUN MELSUNGEN AG
  • NXSTAGE MEDICAL, INC.
  • 旭化成メディカル
  • CENTRAL ADMIXTURE PHARMACY SERVICES, INC.
  • FRESENIUS MEDICAL CARE AG.
  • 日機装
  • INFORMED SA
  • 東レ・メディカル
  • MEDICA S.P.A.
  • MEDICAL COMPONENTS INC.
  • BELLCO SRL
  • MEDITES PHARMA
  • DIAVERUM
  • テルモBCT
  • COVIDIEN

図表

目次
Product Code: HME-2221115

The global continuous renal replacement therapy (CRRT) market is growing at the CAGR of 7.69% and will contribute $1290 million till 2022. In regional outlook, market is divided into North America, Europe, Asia Pacific and Rest of the World. Asia Pacific is the fastest growing global continuous renal replacement therapy (CRRT) market, in terms of revenue in forecast period. Increasing geriatric population, rising healthcare infrastructure are the major reasons which boost the Asia Pacific region's growth in the global continuous renal replacement therapy (CRRT) market. India and China are the two major countries in Asia Pacific region. Europe is a dominating region in global continuous renal replacement therapy (CRRT) market. The major reason which enhances the European region is the increasing prevalence of acute kidney injury patients, approval of anti-coagulants and CRRT machine for multiple applications. North American region is also a growing market for global continuous renal replacement therapy (CRRT) market. The reason being the presence of large number of major players in this area, rising prevalence of kidney failure due to rising diabetes, cancer and other chronic diseases. Rest of the world is showing low market growth, but government initiatives regarding kidney diseases therapies is expected to fuel the market growth in this region. Brazil is the major country in terms of revenue generation

Global continuous renal replacement therapy (CRRT) market is segmented into therapies, products and regional outlook. In therapies segment, the market is divided into SCUF (slow continuous ultra-filtration), CVVH (continuous venovenous hemofiltration), CVVHD (continuous venovenous hemodialysis) and CVVHDF (continuous venovenous hemodiafiltration). CVVH (continuous venovenous hemofiltration) was a leader in therapies segment of global continuous renal replacement therapy (CRRT) market in 2015. The CVVHDF (continuous venovenous hemodiafiltration) is the fastest growing segment and it is expected to grow even further in the forecast year. In products segment, the market is divided into CRRT systems/ machines, fluid filters, blood purification equipment's, blood line systems, CRRT solutions, CRRT concentrates, dialyzers and other CRRT products. Dialysate dominates the global continuous renal replacement therapy (CRRT) market in product segment and this dominance is expected to continue in forecast period.

The factors like high cost of these systems, as well as the overall procedure involving continuous renal replacement therapy systems and unfavorable medical reimbursement policies are especially affecting the large-scale adoption of continuous renal replacement therapy systems in developing and under-developed countries, which hinders the growth of global continuous renal replacement therapy (CRRT) market. Apart from this, there are many reasons like high cost of continuous renal replacement therapy systems, scarcity of trained staff for handling continuous renal replacement therapy systems, unfavorable medical reimbursement policies in many developing countries and strict rules and regulations in the developed regions are holding back the market.

Some of the major market players are Gambro Baxter, B. Braun Melsungen Ag., Toray Medical Co. Ltd., Fresenius Medical Care Ag., Central Admixture Pharmacy Services, Inc., Asahi Kasei Medical Co., Terumo Bct, Diaverum, Mediates Pharma, Medical Components Inc., etc. Acquisition, mergers and expansions are the key strategies adopted by the market players to sustain in the market.

Table of Contents

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. MARKET DEFINITION AND SCOPE
  • 2.2. KEY FINDINGS
  • 2.3. PARAMETRIC ANALYSIS
    • 2.3.1. PREVALENCE AND INCIDENCES RATE OF SEPSIS
    • 2.3.2. CONSUMPTION OF MEDICAL DEVICES-TOP 10 GEOGRAPHIES
    • 2.3.3. GLOBAL NUMBER OF DIALYSIS PERFORMED ANNUALLY VS. CRRT
    • 2.3.4. REIMBURSEMENT POLICIES
    • 2.3.5. HEALTHCARE EXPENDITURE ACROSS GEOGRAPHIES
    • 2.3.6. DISPOSABLE INCOME OF TOP EMERGING ECONOMIES
  • 2.4. KEY MARKET INSIGHTS
    • 2.4.1. TOP 3 EMERGING COUNTRIES
    • 2.4.2. TOP 3 REVENUE GENERATING SEGMENTS
    • 2.4.3. TOP GROWING MARKETS AND EMERGING TRENDS
    • 2.4.4. R&D SCENARIO
      • 2.4.4.1. PEDIATRIC CRRT SYSTEMS
    • 2.4.5. PRICING ANALYSIS
      • 2.4.5.1. CRRT VS. INTERMITTENT HEMODIALYSIS (IHD)
  • 2.5. COMPETITIVE INTELLIGENCE
    • 2.5.1. MARKET SHARE ANALYSIS
    • 2.5.2. TOP WINNING STRATEGIES
    • 2.5.3. CASE STUDIES: TOP COMPETITIVE MOVES
  • 2.6. VALUE CHAIN ANALYSIS
  • 2.7. KEY BUYING CRITERIA
  • 2.8. STRATEGIC RECOMMENDATION
  • 2.9. STRATEGIC CONCLUSIONS

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. INCREASING CASES OF ACUTE KIDNEY INJURIES AND ACUTE RENAL FAILURE
    • 3.1.2. GROWING ADOPTION OF CRRT IN HOSPITALS AND CLINICS
    • 3.1.3. INCREASING PREVALENCE OF SEPSIS, DIABETES AND CANCER ASSOCIATED RENAL FAILURES
    • 3.1.4. ADVANTAGES OF CRRT OVER HEMODIALYSIS MAKES IT MORE PREFERRED TREATMENT METHOD
    • 3.1.5. TECHNOLOGICAL ADVANCEMENTS, INNOVATIONS AND RESEARCH CREATING NEW MARKET OPPORTUNITIES.
    • 3.1.6. AGEING POPULATION
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. SHORTAGE OF TRAINED PROFESSIONALS
    • 3.2.2. COST OF CRRT IS COMPARATIVELY HIGHER THAN INTERMITTENT HEMODIALYSIS (IHD)
    • 3.2.3. LIMITED NUMBER OF MARKET PLAYERS
    • 3.2.4. GOVERNMENT REGULATIONS
  • 3.3. MARKET CHALLENGES
    • 3.3.1. REGULAR HEMODIALYSIS STILL A MORE PREFERRED TREATMENT METHOD IN EMERGING MARKETS
    • 3.3.2. AWARENESS RELATED TO CRRT IS LOW COMPARED TO OTHER HEMOFILTRATION/ BLOOD PURIFICATION TECHNIQUES.
    • 3.3.3. LACK OF CLINICAL EVIDENCES
    • 3.3.4. REIMBURSEMENT ISSUES IN EMERGING MARKETS
  • 3.4. MARKET OPPORTUNITIES
    • 3.4.1. DEVELOPMENT OF PEDIATRIC CRRT SYSTEMS
    • 3.4.2. OPPORTUNITIES IN EMERGING MARKETS OF INDIA AND CHINA WITH HIGH PREVALENCE OF RENAL FAILURES

4. SECTOR ANALYSIS

  • 4.1. PARENT MARKET
  • 4.2. SUB-SEGMENT MARKET
  • 4.3. ALTERNATIVE MARKET

5. MARKET SEGMENTATION

  • 5.1. GLOBAL CRRT MARKET, BY THERAPIES 2014-2022 ($ MILLION)
    • 5.1.1. GLOBAL SCUF (SLOW CONTINUOUS ULTRA FILTRATION) MARKET 2014-2022 ($ MILLION)
    • 5.1.2. GLOBAL CVVH (CONTINUOUS VENOVENOUS HEMOFILTRATION) MARKET 2014-2022 ($ MILLION)
    • 5.1.3. GLOBAL CVVHD (CONTINUOUS VENOVENOUS HEMODIALYSIS) MARKET 2014-2022 ($ MILLION)
    • 5.1.4. GLOBAL CVVHDF (CONTINUOUS VENOVENOUS HEMODIAFILTRATION) MARKET 2014-2022 ($ MILLION)
  • 5.2. GLOBAL CRRT MARKET, BY PRODUCTS 2014-2022 ($ MILLION)
    • 5.2.1. CRRT SYSTEMS/MACHINES MARKET 2014-2022 ($ MILLION)
    • 5.2.2. FLUID FILTERS MARKET 2014-2022 ($ MILLION)
    • 5.2.3. BLOOD PURIFICATION EQUIPMENTS MARKET 2014-2022 ($ MILLION)
    • 5.2.4. BLOOD LINE SYSTEMS MARKET 2014-2022 ($ MILLION)
    • 5.2.5. CRRT SOLUTIONS MARKET 2014-2022 ($ MILLION)
    • 5.2.6. CRRT CONCENTRATES MARKET 2014-2022 ($ MILLION)
    • 5.2.7. DIALYZERS MARKET 2014-2022 ($ MILLION)
    • 5.2.8. OTHER CRRT PRODUCTS MARKET 2014-2022 ($ MILLION)

6. COMPETITIVE LANDSCAPE

  • 6.1. MARKET SHARE
  • 6.2. STRATEGY - AN ANALYSIS ACROSS TIERS

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA CRRT MARKET 2014-2022 ($ MILLION)
  • 7.2. UNITED STATES (U.S.) CRRT MARKET 2014-2022 ($ MILLION)
  • 7.3. CANADA CRRT MARKET 2014-2022 ($ MILLION)
  • 7.4. EUROPE CRRT MARKET 2014-2022 ($ MILLION)
    • 7.4.1. UNITED KINGDOM (UK) CRRT MARKET 2014-2022 ($ MILLION)
    • 7.4.2. FRANCE CRRT MARKET 2014-2022 ($ MILLION)
    • 7.4.3. GERMANY CRRT MARKET 2014-2022 ($ MILLION)
    • 7.4.4. SPAIN CRRT MARKET 2014-2022 ($ MILLION)
    • 7.4.5. ITALY CRRT MARKET 2014-2022 ($ MILLION)
    • 7.4.6. ROE CRRT MARKET 2014-2022 ($ MILLION)
  • 7.5. ASIA PACIFIC CRRT MARKET 2014-2022 ($ MILLION)
    • 7.5.1. INDIA CRRT MARKET 2014-2022 ($ MILLION)
    • 7.5.2. CHINA CRRT MARKET 2014-2022 ($ MILLION)
    • 7.5.3. JAPAN CRRT MARKET 2014-2022 ($ MILLION)
    • 7.5.4. KOREA CRRT MARKET 2014-2022 ($ MILLION)
    • 7.5.5. AUSTRALIA CRRT MARKET 2014-2022 ($ MILLION)
    • 7.5.6. ROAPAC CRRT MARKET 2014-2022 ($ MILLION)
  • 7.6. REST OF THE WORLD CRRT MARKET 2014-2022 ($ MILLION)
    • 7.6.1. LATIN AMERICA CRRT MARKET 2014-2022 ($ MILLION)
    • 7.6.2. MENA CRRT MARKET 2014-2022 ($ MILLION)
    • 7.6.3. AFRICA CRRT MARKET 2014-2022 ($ MILLION)

8. COMPANY PROFILES:

  • 8.1. BAXTER INTERNATIONAL
  • 8.2. GAMBRO BAXTER
  • 8.3. B. BRAUN MELSUNGEN AG
  • 8.4. NXSTAGE MEDICAL, INC.
  • 8.5. ASAHI KASEI MEDICAL CO., LTD.
  • 8.6. CENTRAL ADMIXTURE PHARMACY SERVICES, INC. ( A B BRAUN COMPANY)
  • 8.7. FRESENIUS MEDICAL CARE AG.
  • 8.8. NIKKISO CO.
  • 8.9. INFORMED SA
  • 8.10. TORAY MEDICAL CO. LTD.
  • 8.11. MEDICA S.P.A.
  • 8.12. MEDICAL COMPONENTS INC.
  • 8.13. BELLCO SRL
  • 8.14. MEDITES PHARMA
  • 8.15. DIAVERUM
  • 8.16. TERUMO BCT
  • 8.17. COVIDIEN (MEDTRONIC MINIMALLY INVASIVE)

LIST OF TABLE

  • 1. GLOBAL CRRT MARKET, BY THERAPIES 2014-2022 ($ MILLION)
  • 2. GLOBAL SCUF (SLOW CONTINUOUS ULTRA FILTRATION) MARKET 2014-2022 ($ MILLION)
  • 3. GLOBAL CVVH (CONTINUOUS VENOVENOUS HEMOFILTRATION) MARKET 2014-2022 ($ MILLION)
  • 4. GLOBAL CVVHD (CONTINUOUS VENOVENOUS HEMODIALYSIS) MARKET 2014-2022 ($ MILLION)
  • 5. GLOBAL CVVHDF (CONTINUOUS VENOVENOUS HEMODIAFILTRATION) MARKET 2014-2022 ($ MILLION)
  • 6. GLOBAL CRRT MARKET, BY PRODUCTS 2014-2022 ($ MILLION)
  • 7. CRRT SYSTEMS/MACHINES MARKET 2014-2022 ($ MILLION)
  • 8. FLUID FILTERS MARKET 2014-2022 ($ MILLION)
  • 9. BLOOD PURIFICATION EQUIPMENTS MARKET 2014-2022 ($ MILLION)
  • 10. BLOOD LINE SYSTEMS MARKET 2014-2022 ($ MILLION)
  • 11. CRRT SOLUTIONS MARKET 2014-2022 ($ MILLION)
  • 12. CRRT CONCENTRATES MARKET 2014-2022 ($ MILLION)
  • 13. DIALYZERS MARKET 2014-2022 ($ MILLION)
  • 14. OTHER CRRT PRODUCTS MARKET 2014-2022 ($ MILLION)
  • 15. NORTH AMERICA CRRT MARKET 2014-2022 ($ MILLION)
  • 16. EUROPE CRRT MARKET 2014-2022 ($ MILLION)
  • 17. ASIA PACIFIC CRRT MARKET 2014-2022 ($ MILLION)
  • 18. REST OF THE WORLD CRRT MARKET 2014-2022 ($ MILLION)

LIST OF FIGURES

  • 1. UNITED STATES (U.S.) CRRT MARKET 2014-2022 ($ MILLION)
  • 2. CANADA CRRT MARKET 2014-2022 ($ MILLION)
  • 3. UNITED KINGDOM (UK) CRRT MARKET 2014-2022 ($ MILLION)
  • 4. FRANCE CRRT MARKET 2014-2022 ($ MILLION)
  • 5. GERMANY CRRT MARKET 2014-2022 ($ MILLION)
  • 6. SPAIN CRRT MARKET 2014-2022 ($ MILLION)
  • 7. ITALY CRRT MARKET 2014-2022 ($ MILLION)
  • 8. ROE CRRT MARKET 2014-2022 ($ MILLION)
  • 9. INDIA CRRT MARKET 2014-2022 ($ MILLION)
  • 10. CHINA CRRT MARKET 2014-2022 ($ MILLION)
  • 11. JAPAN CRRT MARKET 2014-2022 ($ MILLION)
  • 12. KOREA CRRT MARKET 2014-2022 ($ MILLION)
  • 13. AUSTRALIA CRRT MARKET 2014-2022 ($ MILLION)
  • 14. ROAPAC CRRT MARKET 2014-2022 ($ MILLION)
  • 15. LATIN AMERICA CRRT MARKET 2014-2022 ($ MILLION)
  • 16. MENA CRRT MARKET 2014-2022 ($ MILLION)
  • 17. AFRICA CRRT MARKET 2014-2022 ($ MILLION)
Back to Top